Safeguard Scientifics Inc. (SFE) Stock Price Down 1.4%
Safeguard Scientifics Inc. (NYSE:SFE)’s share price dropped 1.4% on Monday . The stock traded as low as $12.18 and last traded at $12.33, with a volume of 58,832 shares changing hands. The stock had previously closed at $12.50.
Separately, Zacks Investment Research upgraded Safeguard Scientifics from a “hold” rating to a “buy” rating and set a $14.00 target price on the stock in a research report on Friday, March 18th.
The stock’s market cap is $247.88 million. The firm’s 50-day moving average is $12.80 and its 200-day moving average is $13.03.
Safeguard Scientifics (NYSE:SFE) last issued its earnings results on Thursday, April 28th. The company reported ($0.76) earnings per share for the quarter, missing the consensus estimate of ($0.60) by $0.16. During the same period last year, the firm earned ($0.70) earnings per share. Analysts expect that Safeguard Scientifics Inc. will post ($0.74) EPS for the current year.
Several hedge funds and institutional investors have recently modified their holdings of SFE. Heartland Advisors Inc. purchased a new position in shares of Safeguard Scientifics during the fourth quarter valued at $4,353,000. Bank of Montreal Can raised its position in shares of Safeguard Scientifics by 3.7% in the fourth quarter. Bank of Montreal Can now owns 542,390 shares of the company’s stock valued at $7,870,000 after buying an additional 19,168 shares during the period. Finally, Teton Advisors Inc. raised its position in shares of Safeguard Scientifics by 0.5% in the fourth quarter. Teton Advisors Inc. now owns 195,492 shares of the company’s stock valued at $2,837,000 after buying an additional 1,000 shares during the period.
Safeguard Scientifics, Inc provides capital, as well as strategic, operational and management resources. Safeguard participates in growth and expansion financings and early-stage financings. The Company operates in two reportable segments: Healthcare and Technology. It focuses on companies with initial capital requirements between $5 million and $15 million, and follow-on financing needs of between $5 million and $10 million, with a total anticipated deployment of up to $25 million from it.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.